It appears the manufacturer of Fosamax, the osteoporosis drug, knew about potential serious problems with the drug back in 2004. Fosamax belongs to a family of drugs called bisphosphonates which are believed to cause a severe osteonecrosis. Merck has made $3million from Fosamax and didn’t want to change its labeling for fear of declining sales. Sound familiar?
Admitted to practice law in all federal multidistrict litigation courts, the California State Bar and the Florida Bar. His philosophy is to provide aggressive, quality representations and seek fair compensation for individuals and their families who have suffered injury, death, or sexual abuse.
Comments for this article are closed.